![John N. Abelson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
John N. Abelson
Gründer bei The Agouron Institute
Aktive Positionen von John N. Abelson
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
California Institute of Technology
![]() California Institute of Technology Other Consumer ServicesConsumer Services California Institute of Technology provides education focusing on science, engineering, academia, business, and public service. The company was founded in 1891 and it is headquartered in Pasadena, CA. | Corporate Officer/Principal | - | - |
The Agouron Institute | Direktor/Vorstandsmitglied | - | - |
Gründer | - | - |
Karriereverlauf von John N. Abelson
Ehemalige bekannte Positionen von John N. Abelson
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Melinta Subsidiary Corp.
![]() Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Melinta Subsidiary Corp. develops and markets pharmaceutical products for the treatment of life-threatening infections. It also develops novel classes of antibiotics to treat the multi- and extremely-drug-resistant pathogens for which there are few to no options, known collectively as ESKAPE pathogens. The company was founded by John N. Abelson, Harry F. Noller, Susan Froshauer, Harry H. Penner, Jr., William L. Jorgensen, Thomas A. Steitz, and Peter Moore in October 2000 and is headquartered in New Haven, CT. | Gründer | 01.10.2000 | - |
Statistik
International
Vereinigte Staaten | 4 |
Operativ
Founder | 2 |
Corporate Officer/Principal | 1 |
Director/Board Member | 1 |
Sektoral
Health Technology | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Melinta Subsidiary Corp.
![]() Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Melinta Subsidiary Corp. develops and markets pharmaceutical products for the treatment of life-threatening infections. It also develops novel classes of antibiotics to treat the multi- and extremely-drug-resistant pathogens for which there are few to no options, known collectively as ESKAPE pathogens. The company was founded by John N. Abelson, Harry F. Noller, Susan Froshauer, Harry H. Penner, Jr., William L. Jorgensen, Thomas A. Steitz, and Peter Moore in October 2000 and is headquartered in New Haven, CT. | Health Technology |
The Agouron Institute |
- Börse
- Insiders
- John N. Abelson
- Erfahrung